Brand | Abnova |
Product type | Primary antibodies |
Reactivity | Human |
Host species | Rabbit |
Applications | WB,ELISA,IHC-P |
Brand: | Abnova |
Reference: | PAB10051 |
Product name: | GLI2 polyclonal antibody |
Product description: | Rabbit polyclonal antibody raised against synthetic peptide of GLI2. |
Gene id: | 2736 |
Gene name: | GLI2 |
Gene alias: | HPE9|THP1|THP2 |
Gene description: | GLI-Kruppel family member GLI2 |
Immunogen: | A synthetic peptide corresponding to amino acids 46-60 of human GLI2. |
Protein accession: | P10070;NP_084655(isoformalpha) |
Form: | Liquid |
Recommend dilutions: | ELISA (1:10,000-1:3,0000) Western Blot (1:500-1:2000) Immunohistochemistry (1:500-1:2000) The optimal working dilution should be determined by the end user. |
Storage buffer: | In 20 mM KH2PO4, 150 mM NaCl, pH 7.2 (0.01% sodium azide) |
Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Product type: | Primary antibodies |
Host species: | Rabbit |
Antigen species / target species: | Human |
Specificity: | Expect reactivity with all isoforms of this protein. |
Reactivity: | Human |
Application image: | ![]() |
Application image note: | Immunohistochemistry of GLI2 polyclonal antibody (Cat # PAB10051) shows strong cytoplasmic and membranous staining of tumor cells in human breast tissue. Tissue was formalin-fixed and paraffin embedded. Brown color indicates presence of protein, blue color shows cell nuclei. Personal Communication, Kenneth Wester, www.proteinatlas.org, Uppsala, Sweden. |
Applications: | WB,ELISA,IHC-P |
Shipping condition: | Dry Ice |
Publications: | The zinc-finger transcription factor GLI2 antagonizes contact inhibition and differentiation of human epidermal cells.Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Ikram MS, Quinn AG, Philpott MP, Frischauf AM, Aberger F. Oncogene. 2004 Feb 12;23(6):1263-74. |